Rabies Vaccines
Inactivated cell-culture vaccines for pre- and post-exposure prophylaxis
This page catalogs 5 rabies vaccine products spanning US-licensed cell-culture vaccines, European formulations, WHO-prequalified Vero cell products, and regionally licensed alternatives. Rabies vaccines are unique in serving both pre-exposure prophylaxis for at-risk populations and post-exposure prophylaxis following animal bites, with the shift from nerve tissue to cell-culture platforms representing a major safety advance.
Last updated: April 2026.
Rabies Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Imovax Rabies | Rabies vaccine (human diploid cell) | Sanofi Pasteur | Inactivated (HDCV) | FDA Licensed, 1980 | Human diploid cell vaccine |
| RabAvert | Rabies vaccine (purified chick embryo cell) | GSK (Bavarian Nordic) | Inactivated (PCECV) | FDA Licensed, 1997 | Chick embryo cell vaccine |
| Rabipur | Rabies vaccine (purified chick embryo cell) | GSK/Bavarian Nordic | Inactivated (PCECV) | EMA Authorized | European equivalent of RabAvert |
| Verorab | Rabies vaccine (Vero cell) | Sanofi Pasteur | Inactivated (PVRV) | WHO Prequalified | Widely used in Asia and Africa |
| Indirab | Rabies vaccine (Vero cell) | Bharat Biotech | Inactivated (PVRV) | Licensed in India | India-manufactured Vero cell vaccine |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026), EMA Medicines database, WHO Prequalified Vaccines list, and regional regulatory databases. Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.